Envestnet Asset Management
MIRM icon

Envestnet Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Envestnet Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Sell
22,327
-236
-1% -$23.7K ﹤0.01% 2952
2026
Q1 		$2.08M Buy
22,563
+2,077
+10% +$195K ﹤0.01% 2985
2025
Q4 		$1.62M Buy
20,486
+13,684
+201% +$982K ﹤0.01% 2988
2025
Q3 		$499K Buy
6,802
+1,473
+28% +$93.6K ﹤0.01% 3765
2025
Q2 		$271K Buy
+5,329
New +$237K ﹤0.01% 4082

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Envestnet Asset Management's MIRM Position: Q2 2026 in Review

Envestnet Asset Management reduced its Mirum Pharmaceuticals (MIRM) stake by 1% in Q2 2026, selling an estimated $23.7K and leaving 22,327 shares worth $2.61M. The position accounts for ﹤0.01% of the portfolio, ranked #2952.

Envestnet Asset Management first reported a position in MIRM in Q2 2025 and has held it in 5 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Envestnet Asset Management held 22,327 shares of Mirum Pharmaceuticals worth $2.61M as of Q2 2026.
  • Envestnet Asset Management sold 236 Mirum Pharmaceuticals shares in Q2 2026, an estimated $23.7K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2952 holding.
  • Envestnet Asset Management first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.